Prosecution Insights
Prosecution Insights
5 pending office actions • 3 clients • 5 examiners • 4 art units • 0 of 5 (0%) have an AI response strategy ready • 26 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| No statute on record | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHOMER, ISAAC | 1 | 63.1% | +30.7% |
| ATKINSON, JOSHUA ALEXANDER | 1 | 57.1% | +34.0% |
| HOLT, ANDRIAE M | 1 | 48.7% | +21.6% |
| LEE, JIA-HAI | 1 | 50.1% | +48.1% |
| HELLMAN, KRISTINA M | 1 | 66.0% | +54.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18353524 | CYCLOSPORINE FORMULATIONS FOR USE IN THE PREVENTION OR TREATMENT OF PULMONARY CHRONIC GRAFT REJECTION | SHOMER, ISAAC | 1d overdue |
| 17595393 | METHOD FOR PRODUCING NANOPARTICLES | HOLT, ANDRIAE M | 5d |
| 16973782 | PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF | HELLMAN, KRISTINA M | 6d |
| 17198285 | PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF | LEE, JIA-HAI | 9d |
| 17999851 | METHOD FOR PRODUCING A LIPOSOME DISPERSION | ATKINSON, JOSHUA ALEXANDER | 28d |
| Client (Assignee) | Pending OAs |
|---|---|
| Leon-Nanodrugs | 2 |
| UNIVERSITE DE GENEVE | 2 |
| BREATH THERAPEUTICS GMBH | 1 |
| Art Unit | Apps |
|---|---|
| 1612 | 2 |
| 1614 | 1 |
| 1658 | 1 |
| 1654 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18353524 | CYCLOSPORINE FORMULATIONS FOR USE IN THE PREVENTION OR TREATMENT OF PULMONARY CHRONIC GRAFT REJECTION | Breath Therapeutics GmbH | SHOMER, ISAAC | 1612 | Other | Non-Final OA | 1d overdue | Pending | Jul 17, 2023 |
| 17999851 | METHOD FOR PRODUCING A LIPOSOME DISPERSION | Leon-Nanodrugs GmbH | ATKINSON, JOSHUA ALEXANDER | 1612 | Other | Non-Final OA | 28d | Pending | Nov 24, 2022 |
| 17595393 | METHOD FOR PRODUCING NANOPARTICLES | Leon-Nanodrugs GmbH | HOLT, ANDRIAE M | 1614 | §103 | Non-Final OA | 5d | Pending | Nov 16, 2021 |
| 17198285 | PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF | UNIVERSITE DE GENEVE | LEE, JIA-HAI | 1658 | §103 | Final Rejection | 9d | Pending | Mar 11, 2021 |
| 16973782 | PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF | UNIVERSITE DE GENEVE | HELLMAN, KRISTINA M | 1654 | Other | Final Rejection | 6d | Pending | Dec 10, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial